Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.


HHS - 2623 - Pain Management Best Practices Inter-Agency Task Force - Statutory (Congress Created)
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NamePain Management Best Practices Inter-Agency Task ForceAgency NameDepartment of Health and Human Services
Fiscal Year2019Committee Number2623
Original Establishment Date10/24/2017Committee StatusTerminated
Actual Termination Date7/22/2019Committee URLhttps://www.hhs.gov/ash/advisory-committees/pai...
New Committee This FYNoPresidential Appointments*No
Terminated This FYYesMax Number of Members*30
Current Charter Date10/24/2017Designated Fed Officer Position Title*Designated Federal Officer
Date Of Renewal Charter10/24/2019Designated Federal Officer Prefix
Projected Termination Date7/22/2019Designated Federal Officer First Name*Alicia
Exempt From Renewal*NoDesignated Federal Officer Middle Name
Specific Termination AuthorityDesignated Federal Officer Last Name*Richmond Scott
Establishment Authority*Statutory (Congress Created)Designated Federal Officer SuffixMSW
Specific Establishment Authority*Section 101 of P.L.114-198Designated Federal Officer Phone*240-453-2816
Effective Date Of Authority*7/22/2016Designated Federal Officer Fax*
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*alicia.richmond@hhs.gov
Committee Type*Continuing
Presidential*No
Committee Function*National Policy Issue Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Terminate
Legislation to Terminate RequiredNo
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*Under Section 101 of the Comprehensive Addiction and Recovery Act of 2016 (Public Law 114-198) (CARA), the Secretary of Health and Human Services, in cooperation with the Secretary of Veterans Affairs and the Secretary of Defense, is required to convene a Pain Management Best Practices Inter-Agency Task Force. It is stipulated that the Task Force shall identify, review, and, as appropriate, determine whether there are gaps in or inconsistencies between best practices for pain management (including chronic and acute pain) developed by federal agencies. It also is stipulated that not later than one year after it is convened, the Task Force shall propose updates to best practices and recommendations on addressing the gaps or inconsistencies that are identified, as appropriate. The Task Force shall submit the proposed updates and recommendations to relevant federal agencies and the general public. The Task Force also shall develop a strategy for disseminating information about best practices for pain management, including chronic and acute pain, to stakeholders, if appropriate.
How is membership balanced?*The Task Force consists of not more than 30 members. The membership include currently licensed and practicing physicians, dentists, and non-physicians and prescribers; currently licensed and practicing pharmacists and pharmacies; experts in the fields of pain research and addiction research, including adolescent and young adult addiction research; experts on the health of, and prescription opioid use disorders in, members of the Armed Forces and veterans; and experts in the field of minority health. Under CARA Section 101(c)(5), it is stipulated that the membership composition will also include individuals who are appointed to serve as representatives of pain management professional organizations; the mental health treatment community; the addiction treatment community, including individuals in recovery from substance use disorder; pain advocacy groups, including patients; veteran service organizations; groups with expertise on overdose reversal, including first responders; State medical boards; and hospitals. The members are appointed by the Secretary of Health and Human Services, who will ensure that the Task Force membership includes individuals who represent rural and underserved areas.
How frequent & relevant are cmte mtgs?*The charter stipulated that the Task Force meets no less than twice a year, depending upon the availability of funds. These meetings were held in person, included by teleconference or videoconference at the discretion of the DFO. The Task Force discussed topics and issues that are pertinent to its mission. The Task Force’s deliberations during the meetings were critical for developing the report that must be submitted to relevant federal agencies and the general public to comply with the authorizing statute.
Why advice can't be obtained elsewhere?*The Pain Management Best Practices Inter-Agency Task Force (Task Force) is a non-discretionary federal advisory committee. Establishment of the Task Force was statutorily mandated by Congress. The mandate to establish the Task Force can be found in the Comprehensive Addiction and Recovery Act of 2016 (Public Law 114-198) under Section 101. The statute stipulated that the Task Force will consist of representatives of specific federal agencies and non-federal individuals and entities who have expertise and knowledge about the topics and issues that are pertinent to the mission of the Task Force. The membership composition included diverse disciplines and views. The Task Force provided expert advice and recommendations to relevant federal agencies and the general public for development of best practices for pain management and prescribing pain medication and a strategy for disseminating such best practices.
Why close or partially close meetings?All of the meetings of the Task Force were open to the public unless it is determined by the Secretary or designee that a meeting will be closed and/or partially closed because the topics to be discussed are confidential and/or sensitive in nature.
Recommendation RemarksOn May 9 - 10, 2019, the Task Force voted on the final draft recommendations and discussed a strategic dissemination plan. On May 30, 2019, the Task Force Final Report was posted for the public, in accordance with the CARA Act, which stipulated that the final report must be completed one year after the inaugural Task Force meeting.. On June 26, 2019, the Task Force with CMS convened the Task Force via teleconference to discuss payment and coverage policies for chronic and acute pain, service delivery models, access to therapies and medical devices, and other issues outlined in section 6032 of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act.

A final report resource kit was developed for the public. This Resource kit includes a set of factsheets and infographics that summarize information from the Report that can help communicate recommendations for improving pain management. The topics are education, patient safety, access to care, stigma, special populations and military service members. For information visit, https://www.hhs.gov/ash/advisory-committees/pain/reports/index.html.

The expended costs for FY 19 were less than anticipated. The CARA Act stipulated that this federal advisory committee (the Task Force) ends in 3 years from the enactment of the Act. On July 22, 2019 the Task Force sunset. Since the federal advisory committee ended mid-year, there was no need for an additional series of subcommittee meetings or in-person open meeting to be held for which the remaining funds would have expended to implement.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*No
Outcome Trust In GovernmentNoAction Reallocate ResourcesNo
Outcome Major Policy ChangesYesAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionNoAction CommentNot Applicable
Outcome Implement Laws/Reg RequirementsNoGrants Review*No
Outcome OtherYesNumber Of Grants Reviewed 
Outcome CommentUnder CARA Section 101, the Task Force is required to propose recommendations that address gaps and inconsistencies in clinical best practice guidelines on pain management. During the second Task Force meeting, on September 25-26, 2018, draft recommendations were voted on which were posted for a 30 day public comment period in the first quarter of FY 19. Draft final recommendations were voted on during the third Task Force meeting held on May 9 - 10, 2019.

Under "other costs," the following were included supportive contracts ($308,371) and overhead costs ($22,950).
Number Of Grants Recommended 
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended 
Cost Savings CommentNot ApplicableGrants Review CommentNot Applicable
Number Of Recommendations*174Access Contact Designated Fed. Officer*No
Number Of Recommendations CommentNot ApplicableAccess Agency WebsiteNo
% of Recs Fully Implemented* Access Committee WebsiteYes
% of Recs Fully Implemented CommentNot ApplicableAccess GSA FACA WebsiteNo
% of Recs Partially Implemented* Access PublicationsNo
% of Recs Partially Implemented CommentNot ApplicableAccess OtherNo
Agency Feedback*NoAccess CommentThe final report on pain management can be found at https://www.hhs.gov/sites/default/files/pmtf-final-report-2019-05-23.pdf. It is available on the Task Force webpage at https://www.hhs.gov/ash/advisory-committees/pain/reports/index.html.
Agency Feedback Comment*Not ApplicableNarrative Description*Not Applicable
Hide Section - COSTS

COSTS

Payments to Non-Federal Members* Est Payments to Non-Fed Members Next FY* 
Payments to Federal Members*$7,978.00Est. Payments to Fed Members Next FY* 
Payments to Federal Staff*$234,032.00Estimated Payments to Federal Staff* 
Payments to Consultants* Est. Payments to Consultants Next FY* 
Travel Reimb. For Non-Federal Members*$31,310.00Est Travel Reimb Non-Fed Members nextFY* 
Travel Reimb. For Federal Members* Est Travel Reimb For Fed Members* 
Travel Reimb. For Federal Staff* Est. Travel Reimb to Fed Staff Next FY* 
Travel Reimb. For Consultants* Est Travel Reimb to Consultants Next FY* 
Other Costs$331,321.00Est. Other Costs Next FY* 
Total Costs$604,641.00Est. Total Next FY*$0.00
Federal Staff Support (FTE)*2.00Est. Fed Staff Support Next FY* 
Cost RemarksEst Cost Remarks
Hide Section - Interest Areas

Interest Areas

Category
Area
Food and Drugs
Medical Devices
Health
Health Care
Hospitals
Medical Education
Medical Practitioners
Nutrition
Physical Fitness
Public Health
Aging
Medicine
Diseases
Health and Health Research
Illnesses
Medicine and Dentistry
Rehabilitation
Rehabilitation and Disability
Veterans
Veterans and Veterans' Medical Care
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - SUBCOMMITTEES

SUBCOMMITTEES

Committee

Subcommittees

 
ActionCommittee System IDSubcommittee NameFiscal Year
 COM-032486Education, CAM, & Access to Pain Care2019
 COM-032484Medication, Physical Therapy & Interventional Procedures2019
 COM-032485Psychological Approaches, Risk Assessment & Stigma2019
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-034918Pain Management Best Practices Inter-Agency Task Force2018